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Detailed analyses of 20 patients with sporadic neuroﬁbromatosis type 1 (NF1)microdeletions revealed an unexpected
high frequency of somatic mosaicism (8/20 [40%]). This proportion of mosaic deletions is much higher than
previously anticipated. Of these deletions, 16 were identiﬁed by a screen of unselected patients with NF1. None
of the eight patients with mosaic deletions exhibited the mental retardation and facial dysmorphism usually as-
sociated with NF1 microdeletions. Our study demonstrates the importance of a general screening for NF1 deletions,
regardless of a special phenotype, because of a high estimated number of otherwise undetected mosaic NF1 mi-
crodeletions. In patients with mosaicism, the proportion of cells with the deletion was 91%–100% in peripheral
leukocytes but was much lower (51%–80%) in buccal smears or peripheral skin ﬁbroblasts. Therefore, the analysis
of other tissues than blood is recommended, to exclude mosaicism with normal cells in patients with NF1 micro-
deletions. Furthermore, our study reveals breakpoint heterogeneity. The classic 1.4-Mb deletion was found in 13
patients. These type I deletions encompass 14 genes and have breakpoints in the NF1 low-copy repeats. However,
we identiﬁed a second major type of NF1 microdeletion, which spans 1.2 Mb and affects 13 genes. This type II
deletion was found in 8 (38%) of 21 patients and is mediated by recombination between the JJAZ1 gene and its
pseudogene. The JJAZ1 gene, which is completely deleted in patients with type I NF1 microdeletions and is disrupted
in deletions of type II, is highly expressed in brain structures associated with learning and memory. Thus, its
haploinsufﬁciency might contribute to mental impairment in patients with constitutional NF1 microdeletions.
Conspicuously, seven of the eight mosaic deletions are of type II, whereas only one was a classic type I deletion.
Therefore, the JJAZ1 gene is a preferred target of strand exchange during mitotic nonallelic homologous recom-
bination. Although type I NF1 microdeletions occur by interchromosomal recombination during meiosis, our
ﬁndings imply that type II deletions are mediated by intrachromosomal recombination during mitosis. Thus, NF1
microdeletions acquired during mitotic cell divisions differ from those occurring in meiosis and are caused by
different mechanisms.
Introduction
Neuroﬁbromatosis type 1 (NF1) is one of the most com-
mon autosomal dominant disorders and is caused by
defects of the tumor suppressor gene, NF1 (MIM
162200), in 17q11.2. NF1 is characterized by cafe´-au-
lait spots, neuroﬁbromas, axillary/inguinal freckling,
and Lisch nodules (Huson 1989; Marchuk and Collins
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1994). Optic gliomas, bone malformations, and malig-
nant peripheral nerve sheath tumors are also within the
clinical spectrum of NF1. Furthermore, patients with
NF1 often have problems in visual-spatial tasks, mem-
ory, sustained attention, coordination, language, and be-
havior (Gutmann et al. 1997).
Large deletions of the NF1 gene region have been
observed with a frequency of 4.4% and 4.8%, respec-
tively, in two studies screening 500 and 84 unselected
patients with NF1 (Cnossen et al. 1997; Kluwe et al.
2004). The majority of NF1 microdeletions span ∼1.4
Mb, and, in ∼50% of these cases, the breakpoints were
mapped to low-copy repeats termed “NF1 LCRs” (Lo´-
pez Correa et al. 1999, 2001; Dorschner et al. 2000;
Jenne et al. 2000, 2001). Thus, these NF1 microde-
letions belong to the group of genomic disorders that
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are caused by a nonallelic homologous recombination
(NAHR) between region-speciﬁc LCRs.Well-known ge-
nomic disorders caused by NAHR are Smith-Magenis
syndrome (Chen et al. 1997), DiGeorge syndrome (Edel-
mann et al. 1999; Shaikh et al. 2000), Williams-Beuren
syndrome (Peoples et al. 2000; Valero et al. 2000),
Charcot-Marie-Tooth type 1A (CMT1A), and heredi-
tary neuropathy with liability to pressure palsies (Pentao
et al. 1992; Chance et al. 1994; Reiter et al. 1996).
Predisposition to the deletions or duplications under-
lying these disorders is caused by LCRs and thus the
genomic architecture of the corresponding regions (re-
viewed by Inoue and Lupski [2002] and Shaw and Lup-
ski [2004]).
The NF1 LCRs, which predispose the NF1 gene re-
gion to deletions, have a rather complicated structure.
They are composed of multiple pseudogene exons of the
WI-12393 (KIAA0563-related) gene and segments with
homology to chromosome 19. The proximal NF1 LCR
encompasses 110 kb, whereas the distal NF1 LCR spans
74 kb. These LCRs are separated by ∼1.4 Mb (Dorsch-
ner et al. 2000; Jenne et al. 2000, 2001, 2003; Lo´pez
Correa et al. 2001). The NF1 LCRs probably originated
from several duplication and transposition events dur-
ing primate evolution, since they are absent in the NF1
gene region of the mouse (Jenne et al. 2003).
In addition to the NF1 LCRs, other duplicated se-
quences, namely the JJAZ1 gene and its pseudogene,
are located in the NF1 gene region. The functional
JJAZ1 gene spans 16 exons andmaps 20 kb centromeric
to the distal NF1 LCR (ﬁg. 1). The JJAZ1 pseudogene,
however, encompasses only exons 1–9 and is found 41
kb distal to the proximal NF1 LCR (Jenne et al. 2003).
Within 46 kb of homology between the JJAZ1 and its
pseudogene, the overall identity is 97%. The JJAZ1
gene and its pseudogene are located in direct orientation
to one another. Recently, we identiﬁed an NF1 micro-
deletion with breakpoints in the JJAZ1 gene and its
pseudogene (Petek et al. 2003). However, this has been
the only deletion with breakpoints in the JJAZ1 gene
reported so far. The frequency of JJAZ1-mediated mi-
crodeletions, however, has remained unclear.
Patients with NF1 and large deletions often suffer
from amore severe and atypical manifestation of disease
than do the general group of patients who have NF1
with intragenic mutations. The severe and atypical phe-
notype is characterized by lowered mean IQ or mental
retardation, facial dysmorphism, and increased risk for
malignant peripheral nerve sheath tumors (Kayes et al.
1994; Wu et al. 1995; Leppig et al. 1997; Tonsgard et
al. 1997; Wu et al. 1997; De Raedt et al. 2003). How-
ever, it is difﬁcult to distinguish between patients with
deletions and those without deletions solely on the basis
of clinical observations. Furthermore, themajority of pre-
vious deletion studies included only preselected patients
with facial anomalies and mental retardation, whereas
patients without such clinical features have usually been
excluded from the deletion screening. Thus, solid evi-
dence has been missing for the widely accepted associ-
ation of NF1 microdeletion with facial anomalies
and mental retardation. Additionally, it is not known
whether deletion breakpoint heterogeneity inﬂuences
the manifestation of symptoms in the patients.
Recently, we identiﬁed 24 NF1 gene deletions by
screening unselected patients with NF1 for polymorphic
markers and by using intragenic cosmid probes in FISH
(Kluwe et al. 2004; L. Kluwe, R. Siebert, S. Gesk, R.
Freidrich, S. Tinschert, H. Kehrer-Sawatzki, V.-F.Maut-
ner, unpublished data). Samples of 16 of these 24 pa-
tients were available for further analysis presented here.
Additionally, we included ﬁve further deletions in our
investigations. The extent of these 21 deletions was de-
termined by use of completely sequenced and unam-
biguously mapped BACs, PACs, and cloned PCR prod-
ucts as FISH probes. Furthermore, PCR and sequence
analysis was performed to identify and characterize the
regions of strand exchange during the recombination
underlying the deletions.
Material and Methods
Patients
The main phenotypic features of 22 patients withNF1
investigated in this study are summarized in table 1. All
patients fulﬁll the diagnostic criteria for NF1 (Gutmann
et al. 1997). Twelve patients examined here were among
the 22 identiﬁed by an unselected screening of patients
with NF1 performed by use of combined microsatellite
marker typing and subsequent FISH (Kluwe et al. 2004).
The deletions in patients 1180, 1277, 270, and 284 were
identiﬁed in an updated unselected screen. Thus, in total,
16 deletions were identiﬁed on the basis of unselected
screening. We investigated the deletions of six additional
patients who were identiﬁed by a selective screening be-
cause of a severe phenotype (patients Z41, SR, HC, and
SB) or during loss-of-heterogeneity (LOH) analysis of
neuroﬁbromas from different parts of the body (patient
KCD). Patient WB is the mother of patient SB and is
mildly affected, whereas the daughter has a severe phe-
notype. Among the 22 patients indicated in table 1, 20
patients were sporadic cases, and patients 1277 and SB
were familial cases. The study protocol was approved
by the institutional review board, and all participants
provided informed consent.
Cell Lines
Somatic cell hybrids were generated by polyethyle-
neglycol-mediated fusion of thymidine-kinase–deﬁcient
mouse cell line B82 and either Epstein-Barr virus (EBV)–
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Table 1
Physical Features of Patients with NF1 Microdeletions
Patient
Age
(Years) Sex
No. of
Neuroﬁbromas
Dysmorphic
Facial
Featuresa
Mental
Retardation Other Features
Type of
Deletion Mosaic
442b 25 M 11,000 Yes Yesc High burden of subcutaneous tumors, spinal
tumors
I No
619b 15 F 10 Yes Yesd Astrocytoma I No
270 21 M 1600 Yes Yesc Plexiform neuroﬁbroma I No
801b 38 F 11,000 Yes Yes Plexiform neuroﬁbroma I No
Z41 9 F … Yese Yesc Delayed motoric development, ataxia, hamar-
tomas of thalamus
I No
SR 4 M 1 Yes Yesc Large ears, short stature, hyperactivity,
hypogonadism, brachydactyly, camptodac-
tyly, kyphoscoliosis
I No
1180 15 F … … Yes MPNST I No
752b 22 F … ? Yes … I No
450b 9 F … No Yesc … I No
284 40 F … … Yes … I No
1277 3 M … … ? Family history I No
HC 9 M 130 … Yesc Delayed motoric development,
hamartomas of thalamus and globus
pallidus
II No
SB 35 F 1500 Yes Yes Kyphoscoliosis, large feet II No
WBf 65 F 120 No No … II Yes
800b 49 F 1100 No No … I No
659b 47 F 11,000 … No … I Yes
928b 35 F 12 No No … II Yes
697b 11 F 0 No No Slightly handicapped in reading and writing II Yes
488b 33 F 220 No No … II Yes
938b 31 F 3 No No MPNST II Yes
KCD 34 F 1100 No No … II Yes
736b 68 F … No No … II Yes
NOTE.—MPNST p malignant peripheral nerve sheath tumors.
a Dysmorphic features are characterized by hypertelorism, downslanting palpebral ﬁssures, broad nose, and coarse facial appearance.
b These 12 patients were identiﬁed in a previous study of 500 unselected patients (Kluwe et al. 2004). The deletions in patients 1180, 1277, 270,
and 284 were identiﬁed in an updated unselected screen.
c Mild mental retardation.
d Severe mental retardation.
e Dysmorphism in epicanthus.
f Mother of patient SB.
transformed lymphoblastoid cells of patient SB or skin
ﬁbroblasts of patient KCD. To conﬁrm that the hybrids
retained only one chromosome 17, FISH was performed
with BAC 142O6 covering the 5′ end of the NF1 gene
and BAC 55A13 on 17q24; in addition, analyses were
performed of marker D17S849, located in the deleted
interval, and markers D17S1880 and D17S1841, lo-
cated outside the deleted interval.
FISH Analysis
Chromosome spreads were prepared according to
standard methods from whole blood samples, after cul-
turing for 72 h in the presence of phytohemagglutinin
(PHA) (Invitrogen), which mainly stimulates T lympho-
cytes. Therefore, we can not rule out potential selection
for speciﬁc T-lymphocyte populations. After 72 h, col-
cemid was added and the cells were incubated for 15
min in hypotonic solution (0.075 M KCl). After cen-
trifugation, lymphocytes were ﬁxed with methanol and
glacial acetic acid at a ratio of 3:1. The slides prepared
from these suspensions were used for FISH analyses of
metaphase chromosomes and interphase nuclei. Clones
used as FISH probes were purchased from the BACPAC
Resource Center and have been characterized elsewhere
(Jenne et al. 2003). FISH was also performed with probe
DJ1576/1578, which covers the region from positions
67241 to 79694 of PAC 2349P21 (GenBank accession
number AC127024); probe DJHK10/11, which spans
positions 4242–8373 of BAC 307A16 (GenBank acces-
sion number AC003041); and probe DJ1686/1863,
which covers positions 98021–104095 of AC090616.
These FISH probes were generated by PCR by use of
the Expand Long Template PCR System (Roche Molec-
ular Biochemicals) and were cloned with the TOPO TA
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Cloning Kit (Invitrogen). Two-color FISH was per-
formed by use of probes labeled with either biotin-16-
dUTP or digoxygenin-11-dUTP (Roche Diagnostics).
Hybridization signals were visualized with ﬂuorescein
isothiocyanate–avidin and biotinylated anti-avidin (Vec-
tor) or with anti-digoxygenin antibodies coupled to
Texas Red (Dianova). Slides were counterstained with
diamidinophenylindole (DAPI) and mounted with Vec-
tashield antifade solution (Vector). Probes from theNF1
gene region were labeled with biotin and cohybridized
with the digoxygenin-labeled BAC 55A13 (GenBank ac-
cession number AC015651) from 17q24. To investigate
mosaicism with normal cells, slides were hybridizedwith
biotin-labeled BAC RP11-142O6 and digoxygenin-la-
beled BAC RP11-55A13. In blood lymphocytes, at least
200 interphase nuclei were evaluated, and, in buccal
smears, at least 100 interphase cells were evaluated.
PCR with Somatic Cell Hybrids to Narrow the
Deletion Boundaries
PCRwas performed with primers P1–P4 (listed in sup-
plementary table A1 [online-only]) to narrow the dele-
tion boundaries by use of somatic cell hybrids that con-
tain only the chromosome 17 with the microdeletion but
not the normal chromosome 17 of the respective patient.
Oligonucleotides summarized in supplementary table
A2 (online-only) were used for PCR experiments to eval-
uate paralogous sequence variants (PSVs) (also termed
“cis-morphisms”), which distinguish the functional
JJAZ1 gene from its pseudogene. PCR products were se-
quenced by use of an ABI Prism 3100 Genetic Analyzer
(Applied Biosystems).
Deletion-Junction PCR to Detect Breakpoints Located
in the 2-kb Hotspot Region
To determine the frequency of type I deletions with
breakpoints in the 2-kb region of preferred strand
exchange described elsewhere (Jenne et al. 2001; Lo´pez
Correa et al. 2001), PCR was performed with primers
DJ2290 (5′-TCAACCTCCCAGGCTCCCGAA-3′) and
DJ2314 (5′-TTTGCACGTGTGACCTTCCACAG-3′),
which detect PSVs between the proximal and the distal
LCRs at their very 3′ end. Furthermore, these primers
are phosphorothioated at the 3′ residue to avoid cor-
rection of the mismatches by the polymerase. As this
PCR is not very robust and can lead to false-positive
results, PCR products were sequenced to conﬁrm the
authenticity of a true deletion-junction fragment.
Deletion-Junction PCR to Identify Breakpoints in the
JJAZ1 Sequences
To evaluate whether the breakpoints of other type II
deletions map to one of the regions of strand exchange
identiﬁed, PCR was performed with genomic DNA iso-
lated from peripheral blood samples of patients with
type II deletions and with the primers listed in supple-
mentary table A3 (online-only). The primers detect PSVs
at the 3′ end and are phosphorothioated at the 3′ residue.
Thus, the primers discriminate between the JJAZ1 gene
and its pseudogene. PCR was performed by use of the
Expand Long Template PCR System (Roche Molecular
Biochemicals).
Genotyping to Determine the Mechanism Underlying
the Deletions in Patients KCD and WB
Markers proximal to the NF1 gene, D17S1873,
D17S1841, D17S975, and D17S1863, as well as mark-
ers distal to the NF1 gene, D17S1880, D17S907,
D17S1833, and D17S1788, were investigated by 6FAM-
labeled primers and capillary electrophoresis by use of
an ABI Prism 3100 (Applied Biosystems). Markers RsaI
and SNP2 detect SNPs located in exon 5 of the NF1
gene and the RAB11-FIB4 gene, respectively. These lat-
ter markers were ampliﬁed with primers described by
Eisenbarth et al. (2000).
Marker Analysis to Evaluate Mosaicism in Patient 928
Markers D17S2237 and NF1PCR were ampliﬁed by
PCR with primer pairs 5′-CAAGAAAAGCTAATAT-
CGGC-3′ and 5′-GGAACCTTAAGTTCACTTAG-3′
(D17S2237), and 5′-CCTCCCAAAATGCTGGGATTA-
CAG-3′ and 5′-TGAGAGGCCAAGGTGAGAGAATT-
GCTGGA-3′ (NF1PCR), from neuroﬁbroma tissue sec-
tions of patient 928. Heterozygosity of these markers
was detected by electrophoresis by use of an ABI Prism
3100 (Applied Biosystems).
RNA In Situ Hybridization
Pregnant C57Bl/6 mice from overnight matings were
killed by cervical dislocation. The embryos and the adult
mouse brain were ﬁxed with 4% paraformaldehyde at
4C. Serial cryosections of 10 mm were mounted on
slides. RNA in situ hybridization was performed with
antisense and sense riboprobes generated by in vitro
transcription with T7 or Sp6 polymerase in the presence
of a35S-UTP (Amersham Biosciences) from linearized
DNA of IMAGE cDNA clone 6513835 (GenBank ac-
cession number BQ964374), which covers exons 8–16
of the mouse Jjaz1 mRNA. Hybridizations were per-
formed overnight as described elsewhere (Schmid et al.
1989).
Sequence Comparisons
Sequences were aligned by use of the BLAST search
facilities of the National Center for Biotechnology In-
formation (NCBI) server and the Genetics Computer
Group (GCG) software package (Wisconsin package,
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version 10.2). Inverted repeats were identiﬁed by use of
the program Dotter (see the Web site of the Karolinska
Institutet Center for Genomics Research).
Expression Analyses of the Chimeric JJAZ1 Sequence
RNA was isolated from the hybrid cell lines SB-B9,
KCD-3, and IL-39 by use of the RNeasy isolation kit
(Qiagen). Reverse transcription was performed with the
SuperScript transcriptase (Invitrogen). Primers located
in exon 10 (5′-TACGGCTCCTATTGCCAAAC-3′) and
exon 14 (5′-GCCATTCAGGATCCTTTTCA-3′) of the
JJAZ1 gene were used for RT-PCR. Products were then
sequenced to conﬁrm their authenticity.
Results
Characterization of Deletions by FISH and Deletion-
Junction PCR
The extent of 21 NF1 gene deletions was determined
by FISH on metaphase chromosomes by use of seven
BACs and PACs and three PCR products as probes. The
position of these FISH probes in the completely se-
quenced contig of the NF1 gene region is indicated in
ﬁgure 1. Of the 21 deletions, 13 include the region
ﬂanked by BAC 307A16 and PAC 2349P21 (summa-
rized in table 2). In these 13 deletion cases, BAC 271K11
shows a reduced hybridization signal. This BAC spans
the proximal NF1 LCR and cohybridizes to the distal
NF1 LCR. Thus, the breakpoints of these 13 deletions
are located in the NF1 LCRs.
To determine whether the WI-12393 gene is affected
by the deletion, FISH was performed with probe DJ1686/
1863, covering exon 1 and the promoter region of the
WI-12393 gene. No signal was obtained by this probe in
all 13 cases, indicating that the corresponding sequence
is deleted. Therefore, we concluded that the 13 type I NF1
microdeletions span ∼1.4 Mb and lead to hemizygosity
of 14 genes, including the WI-12393 gene.
Breakpoint-spanning PCRs were performed to eval-
uate howmany of these type I deletions have breakpoints
in the 2-kb region of preferred strand exchange described
elsewhere (Jenne et al. 2001; Lo´pez Correa et al. 2001).
A true deletion-junction fragment was identiﬁed in 7 of
12 type I deletions for which DNA was available.
The breakpoints of the remaining eight deletions
are not located in the NF1 LCRs, since BAC 307A16
and PAC 2349P21 are only partially deleted and BAC
271K11 does not decrease in signal intensity (table 2).
To further narrow the breakpoints of these eight type II
deletions, FISH was performed with cloned PCR prod-
ucts DJ1576/1578 and DJHK10/11. In all eight type II
deletions, the corresponding sequences were deleted.
These results imply that the breakpoints map to the
JJAZ1 gene and its pseudogene.
Identiﬁcation of the Deletion Boundaries in the JJAZ1
Sequences by PCR
In two type II deletions, the breakpoints were iden-
tiﬁed by use of DNA of somatic cell hybrids that retain
only the microdeleted chromosome 17 (cell lines SB-B9
and KCD-3). We also investigated hybrid cell line IL-
39, which contains the chromosome 17 with the type II
deletion described elsewhere (Petek et al. 2003).
The deletion boundaries were narrowed by PCR am-
pliﬁcation of products P1–P4 from the DNA of the hy-
brid cell lines. The position of the primers with respect
to the JJAZ1 gene and its pseudogene is indicated in
ﬁgure 2. Products P2, P3, and P4 were speciﬁcally am-
pliﬁed from all three hybrid cell lines (IL-39, SB-B9, and
KCD-3). This indicates that the corresponding regions
are not deleted. The region covered by the product P1,
however, turned out to be deleted in all three hybrids.
PSVs (paralogous sequence variants), which distin-
guish the JJAZ1 gene from the pseudogene, were eval-
uated to identify the regions of strand exchange. These
PSVs were discriminated from polymorphisms by the
comparison to published BAC sequences, by sequence
analysis of PCR products ampliﬁed from three somatic
cell hybrids that contain a nondeleted chromosome 17
and by sequence analysis of PCR products ampliﬁed
from those three hybrids with the recombinant JJAZ1
gene.
In cell line KCD-3, the transition of proximal to distal
PSVs, which indicates the region of strand exchange,was
identiﬁed in intron 4 between nucleotides 29666 and
29776 (BAC 640N20 [GenBank accession number
AC090616]) (ﬁg. 3). The deletion breakpoint in hybrid
IL-39 was mapped in intron 5 between nucleotides
51928 and 51976. The crossover region of the deletion
in patient SB was identiﬁed in intron 8 between nucleo-
tides 61762 and 62015. This latter region includes a
partial L1 and an Alu element. In contrast, the regions
of strand exchange in introns 4 and 5 occurred in single-
copy segments.
Deletion-Junction PCR to Amplify across the Regions
of Strand Exchange in the JJAZ1 Sequences
To evaluate whether the breakpoints of the other six
type II deletions map to one of the identiﬁed regions of
strand exchange, deletion-junction PCRs were per-
formed. These PCRs amplify the breakpoint regions
identiﬁed in introns 4, 5, or 8, respectively. Since the
breakpoint regions in introns 5 and 8 are separated by
only 10 kb, we also investigated the segment between
both regions by deletion-junction PCR. None of the re-
maining six type II deletions was positive for one of these
PCRs.
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Table 2
Characterization of the Deletion Breakpoint Boundaries by FISH and Breakpoint-Spanning PCR Analysis
PATIENT
RESULTS OF FISH ANALYSIS WITH BACS/PACS
DELETION-
JUNCTION
PCR
% OF CELLS WITH
DELETION IN
271K11 2349P21 785C15 142O6 805L22 307A16 55J8
Peripheral
Blood
Other
Tissue
442 P D D D D D N  100 ND
619 P D D D D D N  100 ND
270 P D D D D D N  100 ND
801 P D D D D D N  100 ND
Z41 P D D D D D N ND 100 ND
SR P D D D D D N  100 ND
1180 P D D D D D N  100 ND
752 P D D D D D N  100 ND
450 P D D D D D N  100 ND
284 P D D D D D N  100 100a
1277 P D D D D D N  100 100a
800 P D D D D D N  100 ND
659 P D D D D D N  96 52a
SB N P D D D P N  100 ND
WBb N P D D D P N  94 ND
HC N P D D D P N  100 ND
928 N P D D D P N  100 55a; 80c
697 N P D D D P N  97 59a
488 N P D D D P N  98 56a
938 N P D D D P N  91 80a
KCD N P D D D P N  92 51d
736 N P D D D P N  94 59a
NOTE.—The plus sign () indicates positive deletion-junction PCR, as determined by sequence analysis; the negative sign
() indicates negative deletion-junction PCR, as determined by sequence analysis. Dp deleted; Np not deleted; Pp partially
deleted; ND p not determined.
a Buccal smears.
b Mother of patient SB.
c Neuroﬁbroma.
d Skin ﬁbroblasts cultured from a skin biopsy.
Sequence Analysis of the Breakpoint Regions
The breakpoint regions in introns 4, 5, and 8 of the
JJAZ1 gene were screened for the presence of recom-
binogenic motifs (summarized by Abeysinghe et al.
[2003]). Only in the 253-bp segment of strand exchange
in intron 8 was such a motif found—namely, a translin
binding site.
To identify structural features that might have medi-
ated double-strand breaks during recombination, the
JJAZ1 sequences were scanned for inverted repeats.
These analyses indicated that the region of strand
exchange in intron 5 is ﬂanked by an inverted repeat of
127 bp, with 88% identity. Also, the region of strand
exchange in intron 8 is ﬂanked by a small inverted repeat
of 75 bp, with 74% identity. However, inverted repeats
are not present in the crossover region of intron 4.
The average GC content of the JJAZ1 gene and its
pseudogene is 41%. The GC content of the regions of
strand exchange in introns 4, 5, or 8 is not above this
average.
Expression Analysis of the Recombinant JJAZ1 Fusion
Gene
The recombination between the JJAZ1 pseudogene
and the functional gene leads to a chimeric gene with
the pseudogene at the 5′ end and part of the functional
gene at the 3′ end. RT-PCR and sequencing of the re-
spective products indicated that the recombinant JJAZ1
gene is expressed in hybrid cell lines SB-B9, KCD-3, and
IL-39. Correspondingly, the fusion transcript of the
JJAZ1 pseudogene and the functional JJAZ1 gene is not
prone to nonsense-mediated mRNA decay. It is not very
likely that the chimeric mRNA is efﬁciently translated,
as stop codons are found in exon 2 of the pseudogene,
truncating the ORF prematurely. Additionally, internal
methionine codons located in exons 3 and 4 are not
embedded in a KOZAK sequence.
Mosaicism in Patients with NF1 Microdeletions
Analysis of peripheral blood, buccal mucosa, skin ﬁ-
broblasts, or neuroﬁbroma tissue revealed mosaicism for
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Figure 2 Position of the deletion breakpoints in patients SB and KCD (investigated in this study) and in patient IL (described elsewhere)
(Petek et al. 2003). The precise breakpoints in the JJAZ1 gene and its pseudogene (JJAZ-P) were identiﬁed by use of somatic cell hybrids that
contain only the deleted chromosome 17 (cell lines KCD-3, IL-39, and SB-B9). Black bars indicate the nondeleted regions; white bars represent the
deletion intervals. Exon numbers are given above, and the regions covered by PCR products P1–P4 are marked by gray rectangles.
microdeletions in eight cases (table 2 and supplementary
table A4 [online-only]). Six of the mosaic microdeletions
were found among the 24 patients with deletions who
were identiﬁed by an unselected screen (Kluwe et al.
2004; L. Kluwe, R. Siebert, S. Gesk, R. Freidrich, S.
Tinschert, H. Kehrer-Sawatzki, V.-F. Mautner, unpub-
lished data). This gives a frequency of mosaicism of at
least 26% among the 23 patients with no family history
for NF1 (6/23). In seven of the eight mosaic deletions,
the breakpoints were assigned to the JJAZ1 gene (table
2). A very peculiar form of somatic mosaicism was ob-
served in patient 928. In peripheral blood lymphocytes,
the deletion was detected by FISH in 100% of the cells.
However, in sections of a dermal neuroﬁbroma, 20% of
the nuclei, likely nontumor cells, had two FISH signals
of BAC 142O6. Mosaicism was further conﬁrmed in this
patient by heterozygosity of two markers located in the
NF1 gene in DNA extracted from this tumor. Further-
more, normal cells were detected by FISH in 45% of
buccal cells.
These ﬁndings prompted us to search for mosaicism
in families with a microdeletion in the offspring. Patient
WB is mildly affected, whereas her daughter, SB, has a
severe manifestation and an NF1 microdeletion. Atten-
tive analysis of blood lymphocytes of patient WB re-
vealed mosaicism for a type II deletion she passed on to
her daughter, SB (table 2).
Mechanism Underlying the Deletion in Patients KCD
and WB
The recombination mechanism underlying the mosaic
type II deletions identiﬁed in patients KCD and WB was
evaluated by marker analysis (ﬁg. 4). The haplotypes of
patient KCDwere identiﬁed by use of somatic cell hybrids
that contain only one chromosome 17. Hybrid-line KCD-
101 retains the normal chromosome 17, whereas hybrid
KCD-25 contains the normal chromosomes 17 prior to
the deletion. Hybrid KCD-3, however, contains the chro-
mosome 17 with the microdeletion. In patient SB, the
phase of markers was determined with hybrids that con-
tained either the normal chromosome 17 (SB-B10) or the
microdeleted chromosome 17 (SB-B9). Marker analysis
in the mother, patient WB, was performed with DNA of
an EBV-transformed lymphoblastoid cell line, with 30%
normal cells and 70% microdeleted cells. According to
parsimony considerations, the deletion in patient KCD,
as well as that in patient WB, occurred by intrachro-
mosomal recombination during mitosis.
Expression Analysis of the JJAZ1 Gene by RNA In Situ
Hybridization
In view of the paucity of knowledge about the function
of the JJAZ1 gene, we performed RNA in situ hybrid-
ization by use of mouse tissue sections to identify the
sites of highest Jjaz1 expression (ﬁg. 5A–5H). At an early
developmental stage (embryonal day [ED] 9,5), Jjaz1 is
ubiquitously expressed in the embryo proper and in the
labyrinth of the placenta (ﬁg. 5F). During later devel-
opment, at ED14,5, prominent Jjaz1 expression is no-
ticed in the liver, the lung, and the kidneys, as well as
in the developing neocortex in subventricular zones (ﬁg.
5H). In the adult mouse brain, Jjaz1 is highly expressed
in the hippocampus, the pyriform cortex, the habenula,
the granular cell layer of the cerebellum, and the sur-
rounding Purkinje cells (ﬁg. 5B and 5D).
Discussion
Two Types of NF1 Microdeletions
Previous studies showed that, in ∼50% of NF1 mi-
crodeletions, the breakpoints are located in the NF1
LCRs (Lo´pez Correa et al. 1999, 2001; Dorschner et al.
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Figure 3 Areas of strand exchange in the recombinant JJAZ1 sequences of patients KCD (A), SB (B), and IL (C), as determined by use of
somatic cell hybrids that contain only the chromosome 17 with the deletion found in the respective patient. The regions of strand exchange, marked
by black rectangles, were identiﬁed by the analysis of nucleotide differences between the JJAZ1 gene located distal and its pseudogene located
proximal to the NF1 gene. The nucleotides typical for the JJAZ1 gene are given above the respective lines, and those characteristic for the pseudogene
are given below. White ovals indicate that the sequence ampliﬁed from the hybrid cell line corresponds to the JJAZ1 pseudogene sequence; black
ovals denote matches to the functional JJAZ1 gene. Noninformative polymorphisms (sequence differences among individuals) are represented as
gray ovals. The numbers indicate the position of the respective PSV according to AC090616 (BAC 640N20).
2000; Jenne et al. 2000, 2001). In our sample, 13 (62%)
of 21 deletions have breakpoints in the NF1 LCRs (ta-
ble 2). FISH analyses indicated that the WI-12393
(KIAA0563-related) gene is included in the deleted re-
gion in the 13 type I deletions. Thus, all of the 13 type
I deletions span 1.4 Mb and encompass 14 functional
genes.
Our study further revealed a second major type of
NF1 microdeletion. In 8 (38%) of the 21 deletions, the
breakpoints occurred in the JJAZ1 gene and its pseu-
dogene (table 2). These type II deletions span 1.2 Mb
and encompass only 13 genes, since the functional WI-
12393 gene is retained (ﬁg. 1). It is interesting that seven
(88%) of eight type II deletions are mosaic deletions and
are found in female patients.
Somatic Mosaicism in NF1 Microdeletions
Among the 24 deletions identiﬁed in a previous
(Kluwe et al. 2004) and updated screening of unselected
patients with NF1 (L. Kluwe et al., unpublished data),
6 were found to be mosaic deletions in this study, giving
a minimum frequency of mosaicism of 26% (6/23 cases
without family history). Until now, mosaicism of NF1
microdeletions has been observed in only a few cases
(summarized in Petek et al. 2003). Rasmussen et al.
(1998) detected two mosaic NF1 microdeletions by
LOH analysis and suggested that mosaicism might be
more frequent than was previously assumed. The most
obvious reason for the underestimation of mosaicism is
that deletion screening is mostly restricted to patients
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Figure 4 Genotype analysis to determine that the type II deletion
in patients KCD (A) and WB (B) occurred by intrachromosomal recom-
bination. Eight polymorphic markers that ﬂank the NF1 gene region
and are located outside of the deletion interval were investigated. In
addition, two markers within the deletion interval (RsaI and SNP2)were
analyzed. A, The haplotypes were determined by the analysis of hybrid
cell line KCD-3 with the microdeleted chromosome 17, hybrid cell line
KCD-25 with chromosome 17 prior to the deletion, and hybrid cell line
KCD-101, which retains the unaffected chromosome 17. B, Patient WB
shows mosaicism for the type II deletion. The phase of markers was
determined in her daughter, SB, by use of hybrid cell line SB-10 with
the normal chromosome 17 and cell line SB-B9 with the microdeleted
chromosome 17. The gray rectangles highlight the haplotype of the chro-
mosome with the microdeletion.
with mental retardation and facial dysmorphism. How-
ever, none of the patients with mosaic deletions in our
study had these features. These deletions would not have
been identiﬁed by restricted screens. Our recent screen-
ing included all patients, even those with no clinical in-
dication of an NF1 microdeletion, which enabled the
identiﬁcation of patients with mosaicism.
Another reason for the underestimation of mosaicism
in NF1 microdeletions might be that the number of cells
with the deletion is extremely high in peripheral blood,
the tissue most commonly used for deletion analysis.Our
results demonstrate that, in comparison to peripheral
blood, normal cells are far more frequent in other pe-
ripheral tissues, like buccal smears or skin ﬁbroblasts.
An extreme case of mosaicism is patient 928. The de-
letion was detected by FISH in 100% of the lympho-
cytes. However, normal cells were identiﬁed in 20% of
neuroﬁbroma cells and in 45% of buccal cells. These
ﬁndings suggest that hematopoietic stem cells with an
NF1 microdeletion have a signiﬁcant growth advantage,
compared with normal cells.
Positional Preference of NAHR in NF1 Microdeletions
Speciﬁc sequences or genomic architectural features
predispose to NAHR between duplicated sequences (for
review, see Inoue and Lupski 2002; Stankiewicz and
Lupski 2002; Lupski 2003; Shaw and Lupski 2004). In
some of the LCR-mediated genomic disorders, hotspots
of positional preference for strand exchange during re-
combination were identiﬁed. For instance, a 557-bp re-
gion in the 24-kb CMT1A-REPs in 17p11.2 is involved
in ∼78% of crossovers in CMT1A (Reiter et al. 1998).
In Williams-Beuren syndrome, 127% of deletion break-
points occurred in a 12-kb region of the much-larger
LCRs in 7q11.23 (Bayes et al. 2003). Recently, Bi et al.
(2003) observed that, despite ∼170 kb of high homology,
50% of the recombinant junctions of the 4-Mb deletions
in Smith-Magenis syndrome map to a 12-kb region. As
predicted by reciprocal recombination, junction frag-
ments in patients with dup(17)(p11,2p11.2) were also
mapped to this hotspot region.
Positional preference for recombination was also found
in NF1 LCR–mediated microdeletions in a segment of 2
kb (Jenne et al. 2001; Lo´pez Correa et al. 2001). This
hotspot is conﬁrmed in our study, since 58% of the type
I deletions had breakpoints in this interval. Our results
further indicate that, in addition to the NF1 LCRs, the
JJAZ1 gene is also a preferred region of NAHR leading
to NF1 microdeletions. In three JJAZ1-mediated type II
deletions, the regions of strand exchange were identiﬁed
in introns 4, 5, and 8 of the JJAZ1 gene, respectively (ﬁgs.
2 and 3). The breakpoint regions in introns 5 and 8 are
separated by only 10 kb.
Structural Motifs or Sequence Elements That Stimulate
Strand Exchange between the JJAZ1 Sequences
DNA motifs—like x elements, minisatellite core se-
quences, and several other motifs summarized by Abey-
singhe et al. (2003)—are well known to promote recom-
bination. We screened the breakpoint regions in JJAZ1
420 Am. J. Hum. Genet. 75:410–423, 2004
Figure 5 Expression pattern of the mouse Jjaz1 mRNA in coronal sections of the adult mouse brain (A–D), horizontal sections of ED9,5 (E
and F), and sagittal sections of ED14,5 embryos (G and H). Bright-ﬁeld images are stained with Giemsa (A, C, E, and G). The corresponding dark-
ﬁeld images (B, D, F, andH) indicate as white areas the regions of highest Jjaz1 expression. Amyp amygdala; CA1–3p regions of the hippocampus;
db p decidua basalis; DG p dentate gyrus; e p embryo; fv p primordium of follicle of vibrissae; ge p ganglionic eminence; gtrp trophoblast
giant cell; GrCb p granular cell layer of cerebellum; k p kidney; l p labyrinth; li p liver; lu p lung; MHb p medial habenular nucleus; ncp
neocortex; Hy p hypothalamus; sb p submandibular gland; to p upper and lower molar tooth; Pur p Purkinje cells; Pirp piriform cortex; ys
p yolk sac; and Zi p zona incerta.
introns 4, 5, and 8 for such motifs. Only in the region
of strand exchange in intron 8 was a recombinogenic
motif identiﬁed—namely, a translin binding site. Tran-
slin is known to bind to single-stranded ends of staggered
breaks during DNA repair (Sengupta and Rao 2002).
Translin binding sites were found to be signiﬁcantly
overrepresented near both translocation and deletion
breakpoints (Abeysinghe et al. 2003). It remains to be
experimentally proven whether strand exchange is in-
deed promoted by this mechanism.
Among the structural genomic features that are able
to stimulate recombination are inverted repeats. They
cause double-strand breaks by forming hairpin-like
structures (Gordenin and Resnick 1998), thus initiating
nonhomologous recombination. The breakpoint region
in intron 5 is ﬂanked by an inverted repeat of 127 bp.
Also, the region of strand exchange in intron 8 is ﬂanked
by an inverted repeat of 75 bp. Hypothetically, these
inverted repeats form hairpin loops that cause double-
strand breaks during the recombination process. It has
been suggested that a certain length of perfect identity
of 300–500 bp is required for effective NAHR (Reiter
et al. 1998; Lo´pez Correa et al. 2001; Bi et al. 2003).
To investigate a possible correlation of strand exchange
and regions of perfect identity, we compared the prox-
imal and distal JJAZ1 sequences by pairwise alignment.
In the regions of strand exchange in introns 4 and 5, no
segments of perfect identity larger than 100 bp were
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found. In the region of crossover in intron 8, however,
a segment of 252 bp, with 100% identity, was detected.
In summary, several sequence motifs or structural fea-
tures were identiﬁed that might facilitate strand exchange
in the JJAZ1 sequences. However, none of the identiﬁed
crossover regions reveals conspicuous features like a high
density of recombinogenic motifs or inverted repeats of
2 kb. Such features have been identiﬁed in the breakpoint
regions of SMS-REP–mediated deletions and duplications
(Bi et al. 2003). Deletion-junction PCRs that amplify
across the breakpoints in JJAZ1 introns 4, 5, or 8 were
negative in the other six patients with type II deletions.
Thus, a highly restricted positional preference of NAHR
in the JJAZ1 gene is not very likely. The multitude of
polymorphisms, however, found in introns 4, 5, and 8
indicates that allelic nonaberrant recombination occurs
quite commonly in the respective regions (ﬁg. 3).
Positional Preference for Somatic Nonallelic
Recombination in the JJAZ1 Gene
Conspicuously, the breakpoints of seven of the eight
mosaic deletions are located in the JJAZ1 gene and its
pseudogene. Thus, the JJAZ1 gene is a preferred target
of strand exchange during somatic NAHR, leading to
NF1 microdeletions. Although the NF1 LCRs are also
involved in somatic recombination, as indicated by mo-
saicism of a type I deletion in patient 659, mitotic NAHR
seems to be much more frequent in the JJAZ1 gene and
its pseudogene. The reason for this preference is
unknown.
The function of the JJAZ1 gene, which is completely
deleted in patients with type I NF1 microdeletions and
is disrupted in deletions of type II, is not well charac-
terized. It encodes an 803-aa protein with a zinc-ﬁnger
domain and has extensive homology to the Drosophila
protein Suppressor of zeste (Suz12), which belongs to
the Polycomb group of proteins. It is interesting that
JJAZ1 is highly expressed in the cerebellum, the Purkinje
cells, the pyriform cortex, and the pyramidal cells of the
hippocampus in the mouse brain (ﬁg. 5). Neurons in
these structures are characterized by the highest synaptic
activity in the whole brain (Malenka and Nicoll 1999;
Bliss et al. 2000). The hippocampus is an essential com-
ponent in cognitive function and learning. The cells of
the pyriform cortex are linked to the formation of the
amygdala, which has been associated with a range of
cognitive functions, including emotion, learning, mem-
ory, attention, and perception (Gallagher and Chiba
1996). Therefore, the JJAZ1 gene is a candidate gene
whose haploinsufﬁciency contributes to mental impair-
ment in patients with constitutional NF1microdeletions.
The JJAZ1 gene has recently been shown to be dis-
rupted by the somatically acquired translocation t(7;17)
in endometrial stromal tumors. This translocation leads
to the fusion of the JJAZ1 gene in 17q11.2 with the
JAZF1 gene on chromosome 7, which also encodes for
a protein with a zinc-ﬁnger domain (Koontz et al. 2001).
The breakpoint of t(7;17) was mapped to intron 1 of
the JJAZ1 gene by Koontz et al. (2001). Although the
breakpoints in introns 4, 5, and 8 identiﬁed in NF1
microdeletions in the present study are located more dis-
tally, these data underscore that the JJAZ1 gene is a
preferred target for somatic aberrant recombination.
Recombination Mechanism Underlying Type I and
Type II Deletions
The type II deletions identiﬁed in patients KCD and
WB were mediated by intrachromosomal recombination
(ﬁg. 4). Additionally, the JJAZ1-mediated deletion in pa-
tient IL arose by intrachromosomal NAHR (Petek et al.
2003). In contrast, the majority of type I deletions are
generated by interchromosomal recombination between
the NF1 LCRs during germ-cell development (Lo´pez
Correa et al. 2000). Thus, the underlying mechanism
differs between type I and type II NF1 microdeletions.
Genotype/Phenotype Correlations in Patients with NF1
Microdeletions
Our study clearly indicates breakpoint heterogeneity
among patients with NF1 microdeletions. The 1.4-Mb–
spanning type I deletion includes the functional WI-
12393 gene, which is retained in the smaller type II de-
letion of 1.2 Mb. Mental retardation in patient SB, who
has a type II deletion, shows that WI-12393 hemizy-
gosity does not play a key role in this special phenotype.
Nevertheless, the clinical spectrum of patients with type
I and type II deletions may differ. Further investigations
with larger numbers of clinically well-characterized pa-
tients with NF1 microdeletions are recommended to ad-
dress this issue. Furthermore, somatic mosaicism is a
hitherto-unappreciated factor that inﬂuences genotype/
phenotype correlations. None of the patients with mo-
saicism for an NF1 microdeletion investigated in our
study is mentally retarded or has facial dysmorphism.
Normal facial conﬁguration and intelligence was also
found in patient 800, who had a type I deletion in 100%
of the lymphocytes. We also suspect mosaicism in this
exceptional patient, but somatic tissues other than blood
were not available for further analyses.
In our study, a total of nine patients with deletions
did not exhibit the mental retardation and facial dys-
morphism that was believed to be strictly associatedwith
NF1 microdeletions. These patients would not have been
identiﬁed if the deletion screen had been restricted to
patients with such phenotypes, as was the case in most
previous deletion studies and is still the case in some
laboratories. Our results suggest a general screening for
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NF1 microdeletions, regardless of the presence of special
phenotypes.
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